Resverlogix (STU:RFS) FFO


STU:RFS Resverlogix Corp STU:RFS
39 GF Score
Price €0.05
! 4 Warning Signs
View Full Analysis

What is Resverlogix FFO?

FFO (Funds from operations) only applies to REITs.

STU:RFS
39GF Score
Resverlogix Corp STU:RFS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Resverlogix Business Description

Other Exchanges RVXCF:USARVX:Canada
Address 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
39GF Score

Get the complete analysis for STU:RFS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price